[90Y] YFAPI-46

N/A

Report date: 2025/09/24 16:11:30

Base Information

Drug Name[90Y] YFAPI-46

Drug Alias Name90Y-FAPI-46

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Yttrium > 90Y +[4]

Mechanisms of ActionFibroblast activation protein alpha inhibitorsPositron-emission tomography enhancers

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesGerman Cancer Consortium (Dktk)University of Duisburg-Essen

China Registration ClassN/A

Develop Information

Active CompaniesGerman Cancer Consortium (Dktk)University of Duisburg-Essen

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A